Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cancer Therapy and Immunogenicity of COVID Vaccine (CANINE Trial)

NCT04821570 is registered in ClinicalTrials.gov with University of Kansas Medical Center as lead sponsor.

NCT NCT04821570
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04821570 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cancer Therapy and Immunogenicity of COVID Vaccine (CANINE Trial)
Lead sponsor
University of Kansas Medical Center
Phase
Observational
Overall status
Unknown status
Start date
February 23, 2021
Completion date
March 28, 2025
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, lung cancer, melanoma (skin)